Similar Articles

Alternative electric tumor treatment areas in glioblastoma multiforme treatment: Rationale, preclinical and clinical studies

Ayşe Uyanık, Yusuf Bahap, Alpcan Ateş, Elif Özge Doğan, Oytun Erbaş

DOI: 10.5606/fng.btd.2017.027

Issue: 2017, Volume 3 - Issue 4
0 4980

Current trends in Glioblastoma

Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş

DOI: 10.5606/fng.btd.2021.25074

Issue: 2021, Volume 7 - Issue 3
10880 2824

Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations

Fatime Akgeyik, Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.144

Issue: 2024, Volume 10 - Issue 1
9213 3366

Genetically engineered mice models and generating glioblastoma multiforme in the brain

Yasin Polat, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.147

Issue: 2024, Volume 10 - Issue 1
5198 3384

Balancing Act: NRF2's contradictory roles in cancer progression and therapy

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.160

Issue: 2024, Volume 10 - Issue 3
11867 2538

In silico molecular docking analysis of chlorotoxin-derived peptide interaction with MMP-2

Alper Demirezen

DOI: 10.5606/fng.btd.2026.215

Issue: 2026, Volume 12 - Issue 1
611 828